Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Rituximab to Prevent Recurrence of Proteinuria in Patients Receiving Kidney Transplant for FSGS

NCT01164098 is registered in ClinicalTrials.gov with George W. Burke as lead sponsor.

NCT NCT01164098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01164098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Rituximab to Prevent Recurrence of Proteinuria in Patients Receiving Kidney Transplant for FSGS
Lead sponsor
George W. Burke
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2012
Completion date
October 31, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fsgs, proteinuria